These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 4365350

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hypercalcemia and malignant disease.
    Chopra D, Clerkin EP.
    Med Clin North Am; 1975 Mar; 59(2):441-7. PubMed ID: 1117772
    [Abstract] [Full Text] [Related]

  • 4. Hypercalcemia and cancer: an update.
    Murray TM, Josse RG, Heersche JN.
    Can Med Assoc J; 1978 Oct 21; 119(8):915-20. PubMed ID: 367555
    [Abstract] [Full Text] [Related]

  • 5. [Hypercalcemia associated with malignant neoplastic disorders: attempt at physiopathologic interpretation. 15 cases].
    Bloch-Michel H, Aristoff H, Gorins A, Dussart N.
    Rev Rhum Mal Osteoartic; 1969 Apr 21; 36(4):174-90. PubMed ID: 5402944
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Hypercalcemia in myeloma].
    Abe M.
    Nihon Rinsho; 2007 Dec 21; 65(12):2245-9. PubMed ID: 18069268
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Paraneoplastic syndromes. Hyper- and hypocalcemia: pathogenesis and treatments.
    Gordan GS.
    Ann N Y Acad Sci; 1974 Dec 21; 230():181-6. PubMed ID: 4522866
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical trial on ibandronate in patients with tumor-associated hypercalcemia].
    Wang T, Song ST, Jiang ZF, Bian SG, Wang YJ, Li LQ, Zhu J.
    Zhonghua Zhong Liu Za Zhi; 2004 Dec 21; 26(12):739-41. PubMed ID: 15733393
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravenous etidronate in the management of malignant hypercalcemia.
    Ryzen E, Martodam RR, Troxell M, Benson A, Paterson A, Shepard K, Hicks R.
    Arch Intern Med; 1985 Mar 21; 145(3):449-52. PubMed ID: 3919667
    [Abstract] [Full Text] [Related]

  • 17. Hypocalcemia associated with metastatic bone disease. A retrospective study.
    Raskin P, McClain CJ, Medsger TA.
    Arch Intern Med; 1973 Oct 21; 132(4):539-43. PubMed ID: 4742409
    [No Abstract] [Full Text] [Related]

  • 18. Etiologic factors of hypercalcemia in breast cancer.
    Tashima CK, Samaan NA, Blumenschein GR, Hickey RC.
    Tex Med; 1978 Mar 21; 74(3):52-5. PubMed ID: 635813
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A case of pulmonary calcinosis during diffuse myelomatosis].
    Kempf F, Capesius P, Mugel JL.
    J Radiol Electrol Med Nucl; 1972 Dec 21; 53(12):861-5. PubMed ID: 4265852
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.